Literature DB >> 18602370

Hepatitis B virus X protein mutants exhibit distinct biological activities in hepatoma Huh7 cells.

Xiaohong Liu1, Shuhui Zhang, Jing Lin, Shunmin Zhang, Mark A Feitelson, Hengjun Gao, Minghua Zhu.   

Abstract

The role of the hepatitis B virus X protein (HBx) in hepatocarcinogenesis remains controversial. To investigate the biological impact of hepatitis B virus x gene (HBx) mutation on hepatoma cells, plasmids expressing the full-length HBx or HBx deletion mutants were constructed. The biological activities in these transfectants were analyzed by a series of assays. Results showed that HBx3'-20 and HBx3'-40 amino acid deletion mutants exhibited an increase in cellular proliferation, focus formation, tumorigenicity, and invasive growth and metastasis through promotion of the cell cycle from G0/G1 to the S phase, when compared with the full-length HBx. In contrast, HBx3'-30 amino acid deletion mutant repressed cell proliferation by blocking in G1 phase. The expression of P53, p21(WAF1), p14(ARF), and MDM2 proteins was regulated by expression of HBx mutants. In conclusions, HBx variants showed different effects and functions on cell proliferation and invasion by regulation of the cell cycle progression and its associated proteins expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602370     DOI: 10.1016/j.bbrc.2008.06.087

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  A mutant of HBx (HBxDelta127) promotes hepatoma cell growth via sterol regulatory element binding protein 1c involving 5-lipoxygenase.

Authors:  Qi Wang; Wei-ying Zhang; Li-hong Ye; Xiao-dong Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-02-22       Impact factor: 6.150

Review 2.  Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis.

Authors:  Ming Geng; Xuan Xin; Li-Quan Bi; Lu-Ting Zhou; Xiao-Hong Liu
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

3.  A mutant of hepatitis B virus X protein (HBx Delta 127) enhances hepatoma cell migration via osteopontin involving 5-lipoxygenase.

Authors:  Xuan Zhang; Li-hong Ye; Xiao-dong Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-04-05       Impact factor: 6.150

4.  A mutant of hepatitis B virus X protein (HBxDelta127) promotes cell growth through a positive feedback loop involving 5-lipoxygenase and fatty acid synthase.

Authors:  Qi Wang; Weiying Zhang; Qiang Liu; Xuan Zhang; Na Lv; Lihong Ye; Xiaodong Zhang
Journal:  Neoplasia       Date:  2010-02       Impact factor: 5.715

5.  Upregulation of PP2Ac predicts poor prognosis and contributes to aggressiveness in hepatocellular carcinoma.

Authors:  Shao-Juan Gong; Xiao-Jun Feng; Wei-Hua Song; Jian-Ming Chen; Shou-Mei Wang; Dong-Juan Xing; Ming-Hua Zhu; Shu-Hui Zhang; Ai-Min Xu
Journal:  Cancer Biol Ther       Date:  2015-11-30       Impact factor: 4.742

6.  A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.

Authors:  Ying Shi; Junwei Wang; Yuhe Wang; Anna Wang; Hongliang Guo; Feili Wei; Sanjay R Mehta; Stephen Espitia; Davey M Smith; Longgen Liu; Yulin Zhang; Dexi Chen
Journal:  Cancer Lett       Date:  2015-12-17       Impact factor: 8.679

7.  Hepatitis C virus sensitizes host cells to TRAIL-induced apoptosis by up-regulating DR4 and DR5 via a MEK1-dependent pathway.

Authors:  Zhongfan Deng; Huijuan Yan; Jiajie Hu; Shengwei Zhang; Peng Peng; Qingzhen Liu; Deyin Guo
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

8.  The X protein of hepatitis B virus inhibits apoptosis in hepatoma cells through enhancing the methionine adenosyltransferase 2A gene expression and reducing S-adenosylmethionine production.

Authors:  Quanyan Liu; Jiwei Chen; Li Liu; Jun Zhang; Dongfeng Wang; Lu Ma; Yueming He; Yingle Liu; Zhisu Liu; Jianguo Wu
Journal:  J Biol Chem       Date:  2011-01-19       Impact factor: 5.157

9.  NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway.

Authors:  Jing Zhao; Qiong-Zhu Dong; Fan Zhong; Li-Li Cai; Zhao-Yu Qin; Yang Liu; Cheng-Zhao Lin; Lun-Xiu Qin; Fu-Chu He
Journal:  Oncotarget       Date:  2017-02-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.